Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Medical Research and Opinion|October 15, 2011
Safety and pharmacokinetic evaluation of intravenous colistin methanesulfonate sodium in Japanese healthy male subjectsKaori Mizuyachi, Katsutoshi Hara, Akira Wakamatsu, et al.Journal of Drug Assessment|August 19, 2016
Pharmacokinetics, safety, and tolerability following single-dose migalastat hydrochloride (GR181413A/AT1001) in healthy male Japanese subjectsHiroko Ino, Naoki Takahashi, Takumi Terao, et al.Radiation Research|May 27, 2004
An association between oxidative stress and radiation-induced lymphomagenesisGen Suzuki, Yoshiya Shimada, Tomonori Hayashi, et al.International Journal of Clinical Pharmacology and Therapeutics|June 6, 2013
The safety, pharmacokinetics and pharmacodynamics of a combination of fluticasone furoate and vilanterol in healthy Japanese subjectsNorie Nakahara, Akira Wakamatsu, Rodger Kempsford, et al.Clinical Pharmacology in Drug Development|April 29, 2016
Single-Dose Pharmacokinetics of the CCR9 Receptor Antagonist Vercirnon in Healthy US and Japanese SubjectsLynda J Haberer, Kimberley Hacquoil, Hiroko Ino, et al.Health Physics|June 22, 2002
Reconstruction of two victims' posturing based on the induced radioactivities in their bones in the criticality accident in Tokai-Mura, JapanKiriko Miyamoto, Yoshihito Watanabe, Masae Yukawa, et al.Headache|October 16, 2019
A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese AdultsFumihiko Sakai, Takao Takeshima, Yoshihisa Tatsuoka, et al.Journal of Bone and Mineral Metabolism|March 22, 2020
Correction to: Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trialJunichi Takada, Rajani Dinavahi, Akimitsu Miyauchi, et al.Journal of Bone and Mineral Metabolism|November 11, 2019
Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to romosozumab or teriparatide: a post hoc analysis of the STRUCTURE trialJunichi Takada, Rajani Dinavahi, Akimitsu Miyauchi, et al.Igaku Butsuri : Nihon Igaku Butsuri Gakkai Kikanshi = Japanese Journal of Medical Physics : an Official Journal of Japan Society of Medical Physics|November 18, 2003
An accidental exposure by a medical linear accelerator under constructionSaori Kawamura, Kanae Nishizawa, Toshiyasu Hirama, et al.Pageof 2